Home › Cardiovascular Disease
Cardiovascular Disease clinical trials recruiting in the U.S.
216 studies for Cardiovascular Disease are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- St. Louis, MO20 studies
- Pittsburgh, PA20 studies
- Nashville, TN19 studies
- San Francisco, CA18 studies
- Los Angeles, CA18 studies
- Durham, NC17 studies
- Birmingham, AL17 studies
- Phoenix, AZ16 studies
- Cincinnati, OH16 studies
- Ann Arbor, MI16 studies
- San Diego, CA15 studies
- Indianapolis, IN15 studies
- Rochester, MN15 studies
- Charleston, SC15 studies
- Jacksonville, FL15 studies
- Minneapolis, MN15 studies
- Orlando, FL14 studies
- Columbus, OH14 studies
- Winston-Salem, NC14 studies
- Kansas City, KS14 studies
- Portland, OR13 studies
- Tampa, FL13 studies
- Richmond, VA13 studies
- Baltimore, MD13 studies
- Salt Lake City, UT13 studies
- Arlington, VA13 studies
- Tucson, AZ12 studies
- The Bronx, NY12 studies
- Harrisburg, PA11 studies
- San Antonio, TX11 studies
- Kansas City, MO11 studies
By state
- Alabama22 studies
- Arizona26 studies
- Arkansas9 studies
- California52 studies
- Colorado17 studies
- Connecticut17 studies
- District of Columbia11 studies
- Florida36 studies
- Georgia27 studies
- Idaho4 studies
- Illinois31 studies
- Indiana18 studies
- Iowa8 studies
- Kansas18 studies
- Kentucky15 studies
- Louisiana16 studies
- Maine5 studies
- Maryland31 studies
- Massachusetts38 studies
- Michigan30 studies
- Minnesota31 studies
- Mississippi10 studies
- Missouri26 studies
- Montana3 studies
- Nebraska10 studies
- Nevada7 studies
- New Hampshire5 studies
- New Jersey23 studies
- New Mexico10 studies
- New York41 studies
- North Carolina30 studies
- North Dakota4 studies
- Ohio37 studies
- Oklahoma11 studies
- Oregon14 studies
- Pennsylvania35 studies
- Rhode Island5 studies
- South Carolina21 studies
- South Dakota8 studies
- Tennessee28 studies
- Texas38 studies
- Utah19 studies
- Vermont5 studies
- Virginia25 studies
- Washington15 studies
- West Virginia10 studies
- Wisconsin15 studies
Recently updated studies
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 28, 2026 · NCT07286578Obstructive Sleep Apnea Among Somali-Americans
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT04124848Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565New Heart Imaging Techniques to Evaluate Possible Heart Disease
RecruitingHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT01399385Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
Recruiting
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT06811896Diabetes and Heart Disease Risk in Blacks
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT00001853Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
Recruiting
Ages 40 and older · All sexes · Updated Sep 25, 2026 · NCT07843004ADAPT Micro-Randomized Trial
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06915220Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
RecruitingHealthy volunteers welcome
Ages 18 to 35 · All sexes · Updated Sep 23, 2026 · NCT04916327Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 23, 2026 · NCT07613099NightWare and Cardiovascular Health in Veterans With PTSD
RecruitingHealthy volunteers welcome
Ages 22 to 88 · All sexes · Updated Sep 22, 2026 · NCT06419959A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
Ages 19 to 85 · All sexes · Updated Sep 22, 2026 · NCT01927783Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
RecruitingObservational studyHealthy volunteers welcome
1 Month – 100 Years · All sexes · Updated Sep 22, 2026 · NCT02543996Treatment With Aspirin After Preeclampsia: TAP Trial
RecruitingPhase 4
Ages 18 to 55 · Women · Updated Sep 22, 2026 · NCT06281665A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
Ages 45 to 80 · All sexes · Updated Sep 22, 2026 · NCT07613294CV CARE: CardioVascular Care in PC Patients
Recruiting
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT06202820The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 18, 2026 · NCT05440422Product Surveillance Registry
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Improving the Collaborative Health of Adult Dyads
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05370014Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 18, 2026 · NCT07585968Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07685938Zenith® Fenestrated+ Clinical Study
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04875429Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 25 · All sexes · Updated Sep 17, 2026 · NCT06730113From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.